NASDAQ:INOV - Inovalon Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$10.65 -0.05 (-0.47 %)
(As of 06/18/2018 11:55 AM ET)
Previous Close$10.65
Today's Range$10.60 - $10.70
52-Week Range$8.90 - $17.80
Volume4,143 shs
Average Volume574,508 shs
Market Capitalization$1.63 billion
P/E Ratio46.30
Dividend YieldN/A
Beta1.02

About Inovalon (NASDAQ:INOV)

Inovalon logoInovalon Holdings, Inc., a technology company, provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models in the healthcare industry. The company's platform enables the assessment and enhancement of clinical and quality outcomes and financial performance. It serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. The company provides technology that supports approximately 500 healthcare organizations. Its platforms are informed by data pertaining to approximately 932,000 physicians; 455,000 clinical facilities; and approximately 240 million individuals and 37 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.

Receive INOV News and Ratings via Email

Sign-up to receive the latest news and ratings for INOV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
SectorComputer and Technology
SymbolNASDAQ:INOV
CUSIPN/A
Phone301-809-4000

Debt

Debt-to-Equity Ratio0.31
Current Ratio4.48
Quick Ratio4.48

Price-To-Earnings

Trailing P/E Ratio46.30
Forward P/E Ratio56.05
P/E Growth3.94

Sales & Book Value

Annual Sales$449.36 million
Price / Sales3.61
Cash Flow$0.5976 per share
Price / Cash17.82
Book Value$4.47 per share
Price / Book2.38

Profitability

EPS (Most Recent Fiscal Year)$0.23
Net Income$34.81 million
Net Margins3.20%
Return on Equity2.50%
Return on Assets1.62%

Miscellaneous

Employees2,480
Outstanding Shares152,270,000

Inovalon (NASDAQ:INOV) Frequently Asked Questions

What is Inovalon's stock symbol?

Inovalon trades on the NASDAQ under the ticker symbol "INOV."

How were Inovalon's earnings last quarter?

Inovalon Holdings Inc (NASDAQ:INOV) posted its quarterly earnings results on Tuesday, May, 8th. The technology company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.06 by $0.10. The technology company earned $92.76 million during the quarter, compared to analyst estimates of $107.76 million. Inovalon had a net margin of 3.20% and a return on equity of 2.50%. Inovalon's revenue for the quarter was down 14.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.07 EPS. View Inovalon's Earnings History.

What guidance has Inovalon issued on next quarter's earnings?

Inovalon updated its FY18 earnings guidance on Tuesday, May, 8th. The company provided earnings per share (EPS) guidance of $0.32-0.38 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.39. The company issued revenue guidance of $568-593 million, compared to the consensus revenue estimate of $576.37 million.

What price target have analysts set for INOV?

3 analysts have issued 12-month target prices for Inovalon's stock. Their forecasts range from $10.00 to $14.00. On average, they expect Inovalon's stock price to reach $12.00 in the next year. View Analyst Ratings for Inovalon.

Who are some of Inovalon's key competitors?

Who are Inovalon's key executives?

Inovalon's management team includes the folowing people:
  • Keith R. Dunleavy, Chairman & CEO (Age 49)
  • Mr. Robert A. Wychulis, Pres (Age 63)
  • Mr. John Michael Burgin, Chief Product Officer (Age 44)
  • Ms. Shauna L. Vernal, Former Chief Legal Officer & Corp. Sec. (Age 49)
  • Mr. Jonathan R. Boldt, Interim Chief Financial Officer (Age 33)

When did Inovalon IPO?

(INOV) raised $500 million in an initial public offering on Thursday, February 12th 2015. The company issued 22,200,000 shares at $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank acted as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Has Inovalon been receiving favorable news coverage?

Press coverage about INOV stock has trended somewhat positive this week, Accern Sentiment reports. Accern scores the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Inovalon earned a media sentiment score of 0.13 on Accern's scale. They also assigned media headlines about the technology company an impact score of 41.45 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Who are Inovalon's major shareholders?

Inovalon's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (2.92%), Neuberger Berman Group LLC (2.29%), Tikvah Management LLC (1.36%), Senvest Management LLC (0.88%), Northern Trust Corp (0.59%) and Prescott Group Capital Management L.L.C. (0.44%). Company insiders that own Inovalon stock include Daniel L Rizzo, Joseph R Rostock, Keith R Dunleavy, Lee D Roberts, Robert A Wychulis, Shauna L Vernal, Thomas R Kloster, William D Green and William J Teuber Jr. View Institutional Ownership Trends for Inovalon.

Which institutional investors are selling Inovalon stock?

INOV stock was sold by a variety of institutional investors in the last quarter, including PNC Financial Services Group Inc., Prescott Group Capital Management L.L.C., GSA Capital Partners LLP, Envestnet Asset Management Inc., Northern Trust Corp, Oppenheimer Asset Management Inc., California Public Employees Retirement System and Royal Bank of Canada. Company insiders that have sold Inovalon company stock in the last year include Robert A Wychulis and Shauna L Vernal. View Insider Buying and Selling for Inovalon.

Which institutional investors are buying Inovalon stock?

INOV stock was bought by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Tikvah Management LLC, Millennium Management LLC, Algert Global LLC, Senvest Management LLC, Trexquant Investment LP, Barclays PLC and Cowen Prime Services LLC. Company insiders that have bought Inovalon stock in the last two years include Keith R Dunleavy, Lee D Roberts, Robert A Wychulis, William D Green and William J Teuber Jr. View Insider Buying and Selling for Inovalon.

How do I buy shares of Inovalon?

Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Inovalon's stock price today?

One share of INOV stock can currently be purchased for approximately $10.65.

How big of a company is Inovalon?

Inovalon has a market capitalization of $1.63 billion and generates $449.36 million in revenue each year. The technology company earns $34.81 million in net income (profit) each year or $0.23 on an earnings per share basis. Inovalon employs 2,480 workers across the globe.

How can I contact Inovalon?

Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at 301-809-4000 or via email at [email protected]


MarketBeat Community Rating for Inovalon (INOV)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  156 (Vote Outperform)
Underperform Votes:  219 (Vote Underperform)
Total Votes:  375
MarketBeat's community ratings are surveys of what our community members think about Inovalon and other stocks. Vote "Outperform" if you believe INOV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INOV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.